Intelligent Bio Solutions completes drug screening clinical study

Go back to Intelligent Bio Solutions completes drug screening clinical study
(NASDAQ: INBS) Delayed: 1.95 --0 (-0%)
Previous Close $1.95    52 Week High
Open $1.95    52 Week Low
Day High $1.95    P/E N/A 
Day Low $1.95    EPS
Volume 671